Episurf Medical received another Notice of Allowance from the United States Patent and Trademark Office. The patent, entitled “Determination and visualization of damage to an anatomical joint,” relates to 3D-based assessment of joint lesions and complements Episurf Medical’s earlier U.S. patents within this field.
“With this we get additional IP protection in the US within the important and exciting field of medical imaging and surgical pre-planning. This constitutes an essential part of the company’s Episealer® implant technology,” comments Katarina Flodström, COO, Episurf Medical.
Episurf Medical received another Notice of Allowance from the United States Patent and Trademark Office. The patent, entitled “Determination and visualization of damage to an anatomical joint,” relates to 3D-based assessment of joint lesions and complements Episurf Medical’s earlier U.S. patents within this field.
“With this we get additional...
Episurf Medical received another Notice of Allowance from the United States Patent and Trademark Office. The patent, entitled “Determination and visualization of damage to an anatomical joint,” relates to 3D-based assessment of joint lesions and complements Episurf Medical’s earlier U.S. patents within this field.
“With this we get additional IP protection in the US within the important and exciting field of medical imaging and surgical pre-planning. This constitutes an essential part of the company’s Episealer® implant technology,” comments Katarina Flodström, COO, Episurf Medical.
Copy to clipboard 
